272 related articles for article (PubMed ID: 31004586)
1. Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.
Raman V; Jawitz OK; Yang CJ; Tong BC; D'Amico TA; Berry MF; Harpole DH
Ann Thorac Surg; 2019 Aug; 108(2):377-383. PubMed ID: 31004586
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience.
Sarkaria IS; Iyoda A; Roh MS; Sica G; Kuk D; Sima CS; Pietanza MC; Park BJ; Travis WD; Rusch VW
Ann Thorac Surg; 2011 Oct; 92(4):1180-6; discussion 1186-7. PubMed ID: 21867986
[TBL] [Abstract][Full Text] [Related]
3. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
[TBL] [Abstract][Full Text] [Related]
4. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
5. Pathological features, clinical presentations and prognostic factors of ovarian large cell neuroendocrine carcinoma: a case report and review of published literature.
Yang X; Chen J; Dong R
J Ovarian Res; 2019 Jul; 12(1):69. PubMed ID: 31345245
[TBL] [Abstract][Full Text] [Related]
6. Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
Komiya T; Ravindra N; Powell E
Asian Pac J Cancer Prev; 2021 Feb; 22(2):365-370. PubMed ID: 33639649
[TBL] [Abstract][Full Text] [Related]
7. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Chemotherapy for T4 Non-Small Cell Lung Cancer with Additional Ipsilateral Lung Nodules.
Li AX; Flores K; Canavan ME; Boffa DJ; Blasberg JD
Ann Thorac Surg; 2022 Feb; 113(2):421-428. PubMed ID: 33684345
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.
Veluswamy RR; Mhango G; Bonomi M; Neugut AI; Hershman DL; Aldridge MD; Wisnivesky JP
Ann Am Thorac Soc; 2013 Dec; 10(6):622-8. PubMed ID: 24024700
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Curative-Intent Surgery and Adjuvant Treatment for Pulmonary Large Cell Neuroendocrine Carcinoma.
Kim KW; Kim HK; Kim J; Shim YM; Ahn MJ; Choi YL
World J Surg; 2017 Jul; 41(7):1820-1827. PubMed ID: 28204910
[TBL] [Abstract][Full Text] [Related]
12. Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
Abedallaa N; Tremblay L; Baey C; Fabre D; Planchard D; Pignon JP; Guigay J; Pechoux CL; Soria JC; de Montpreville VT; Besse B
J Thorac Oncol; 2012 Jul; 7(7):1179-83. PubMed ID: 22617247
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer).
Kenmotsu H; Niho S; Ito T; Ishikawa Y; Noguchi M; Tada H; Sekine I; Watanabe S; Yoshimura M; Yamamoto N; Oshita F; Kubota K; Nagai K
Lung Cancer; 2014 Jun; 84(3):254-8. PubMed ID: 24679951
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
[TBL] [Abstract][Full Text] [Related]
15. Survival after adjuvant radiation therapy in localized small cell lung cancer treated with complete resection.
Engelhardt KE; Coughlin JM; DeCamp MM; Denlinger CE; Meyerson SL; Bharat A; Odell DD
J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1665-1677.e2. PubMed ID: 31627955
[TBL] [Abstract][Full Text] [Related]
16. Sublobar resection is associated with decreased survival for patients with early stage large-cell neuroendocrine carcinoma of the lung.
Lutfi W; Schuchert MJ; Dhupar R; Sarkaria I; Christie NA; Yang CJ; Deng JZ; Luketich JD; Okusanya OT
Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):517-524. PubMed ID: 31177277
[TBL] [Abstract][Full Text] [Related]
17. Complete tumor response of a locally advanced lung large-cell neuroendocrine carcinoma after palliative thoracic radiotherapy and immunotherapy with nivolumab.
Mauclet C; Duplaquet F; Pirard L; Rondelet B; Dupont M; Pop-Stanciu C; Vander Borght T; Remmelink M; D'Haene N; Lambin S; Wanet M; Remouchamps V; Ocak S
Lung Cancer; 2019 Feb; 128():53-56. PubMed ID: 30642453
[TBL] [Abstract][Full Text] [Related]
18. Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer.
Drake JA; Portnoy DC; Tauer K; Weksler B
Ann Thorac Surg; 2018 Oct; 106(4):959-965. PubMed ID: 29856974
[TBL] [Abstract][Full Text] [Related]
19. Poor prognosis of ovarian cancer with large cell neuroendocrine carcinoma: case report and review of published works.
Asada K; Kawana K; Teshima S; Saito A; Kawabata M; Fujii T
J Obstet Gynaecol Res; 2014 Mar; 40(3):869-72. PubMed ID: 24738132
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
